Quest PharmaTech (TSXV:QPT) YoY EBITDA Growth : -200.00% (As of Oct. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Quest PharmaTech's YoY EBITDA Growth for the quarter that ended in Oct. 2023 was -200.00%.

Quest PharmaTech's EBITDA per Share for the three months ended in Oct. 2023 was C$-0.02.

Quest PharmaTech YoY EBITDA Growth Historical Data

The historical data trend for Quest PharmaTech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech YoY EBITDA Growth Chart

Quest PharmaTech Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

YoY EBITDA Growth

Get a 7-Day Free Trial

7.14

-51.92

1,534.18

-144.57

91.49

Quest PharmaTech Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
YoY EBITDA Growth	Get a 7-Day Free Trial															90.74	93.79	-416.67	-1,350.00	-200.00

Quest PharmaTech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Quest PharmaTech's YoY EBITDA Growth for the fiscal year that ended in Jan. 2023 is calculated as:

	YoY EBITDA Growth (A: Jan. 2023 )
=	(EBITDA per Share (A: Jan. 2023 )	-	EBITDA per Share (A: Jan. 2022 ))	/	\| EBITDA per Share (A: Jan. 2022 ) \|
=	(-0.043	-	-0.505)	/	\| -0.505 \|
=	91.49 %

Quest PharmaTech's YoY EBITDA Growth for the quarter that ended in Oct. 2023 is calculated as:

	YoY EBITDA Growth (Q: Oct. 2023 )
=	(EBITDA per Share (Q: Oct. 2023 )	-	EBITDA per Share (Q: Oct. 2022 ))	/	\| EBITDA per Share (Q: Oct. 2022 )) \|
=	(-0.015	-	-0.005)	/	\| -0.005 \|
=	-200.00 %

Quest PharmaTech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest PharmaTech (TSXV:QPT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4

Website

http://www.questpharmatech.com

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

Executives

Ragupathy Madiyalakan

Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines